Chundong Yu
Overview
Explore the profile of Chundong Yu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
1249
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zheng J, Lin Z, Li X, Miao F, Maimaitiming T, Ma Y, et al.
ACS Appl Mater Interfaces
. 2025 Feb;
17(10):14859-14872.
PMID: 40014576
Embolotherapy is an effective antitumor method, which essentially blocks the oxygen supply and induces hypoxia to treat tumors; however, traditional practices demand high expertise and harbor risks of complications. This...
2.
Xie F, Niu Y, Chen X, Kong X, Yan G, Zhuang A, et al.
J Pharm Anal
. 2025 Feb;
15(1):101068.
PMID: 39902457
Ursodeoxycholic acid (UDCA) is a naturally occurring, low-toxicity, and hydrophilic bile acid (BA) in the human body that is converted by intestinal flora using primary BA. Solute carrier family 7...
3.
Chen J, Zheng Y, Wang Z, Gao Q, Hao K, Chen X, et al.
BMC Med
. 2025 Jan;
23(1):39.
PMID: 39849483
Background: Esophageal squamous cell carcinoma (ESCC) is often diagnosed at an advanced stage due to the lack of non-invasive early detection tools, which significantly impacts patient prognosis. Given that glycosylation...
4.
Xu Y, Yu C, Zhang H, Wang T, Liu Y, Wu L, et al.
J Cancer
. 2024 Sep;
15(17):5577-5593.
PMID: 39308682
The occurrence and development of hepatocellular carcinoma (HCC) are closely related to abnormal apoptosis. Brf1 is highly expressed in HCC and has clinical prognostic value. Here, attenuation of Brf1-induced apoptosis...
5.
Hong Y, Chen Q, Wang Z, Zhang Y, Li B, Guo H, et al.
Adv Sci (Weinh)
. 2024 Jul;
11(33):e2310037.
PMID: 38953362
Programmed death-ligand 1 (PD-L1) is overexpressed in multiple cancers and critical for their immune escape. It has previously shown that the nuclear coactivator SRC-1 promoted colorectal cancer (CRC) progression by...
6.
Zhang Y, Li B, Hong Y, Luo P, Hong Z, Xia X, et al.
PLoS Pathog
. 2024 Jun;
20(6):e1012316.
PMID: 38905308
Histone demethylase JMJD2D (also known as KDM4D) can specifically demethylate H3K9me2/3 to activate its target gene expression. Our previous study has demonstrated that JMJD2D can protect intestine from dextran sulfate...
7.
Zhuang W, Liu C, Hong Y, Zheng Y, Huang M, Tang H, et al.
J Exp Clin Cancer Res
. 2024 Apr;
43(1):123.
PMID: 38654325
Background: Aberrant fucosylation observed in cancer cells contributes to an augmented release of fucosylated exosomes into the bloodstream, where miRNAs including miR-4732-3p hold promise as potential tumor biomarkers in our...
8.
Li B, Zhang Y, Liu X, Zhang Z, Zhuang S, Zhong X, et al.
J Pharm Anal
. 2024 Apr;
14(4):100915.
PMID: 38634065
Pien Tze Huang (PZH), a class I nationally protected traditional Chinese medicine (TCM), has been used to treat liver diseases such as hepatitis; however, the effect of PZH on the...
9.
Chen Q, Guo P, Hong Y, Mo P, Yu C
Cell Biosci
. 2024 Mar;
14(1):41.
PMID: 38553750
Steroid receptor coactivator-1 (SRC-1, also known as NCOA1) frequently functions as a transcriptional coactivator by directly binding to transcription factors and recruiting to the target gene promoters to promote gene...
10.
Tong Z, Zhang Y, Guo P, Wang W, Chen Q, Jin J, et al.
J Cell Mol Med
. 2024 Mar;
28(7):e18171.
PMID: 38506084
SRC-1 functions as a transcriptional coactivator for steroid receptors and various transcriptional factors. Notably, SRC-1 has been implicated in oncogenic roles in multiple cancers, including breast cancer and prostate cancer....